Sort   by:  
 Page size 
UnknownPotential role of microRNA-126 in the diagnosis of cancers: A systematic review and meta-analysis.
Not available
S-EPMC5008569 | biostudies-literature
UnknownThe efficacy and safety of per-nasal "GTS partner" assisted traction technique for gastric endoscopic submucosal dissection: a prospective single-center randomized clinical trial.
Not available
S-EPMC11615103 | biostudies-literature
UnknownInstant duodenal decompression after endoscopic retrograde cholangiopancreatography can effectively reduce the incidence of post-ERCP pancreatitis and hyperamylasemia.
Not available
S-EPMC10997411 | biostudies-literature
UnknownIdentification of sugar transporter MrSTP20 responding to high-salt stress and hexoses induction in apple rootstock (Malus robusta Rehd).
Not available
S-EPMC12481870 | biostudies-literature
UnknownKey Genomic Regions of Rice Cultivar GuiHeFeng and Its Derivatives Revealed by Genome-Wide Analysis.
Not available
S-EPMC12899404 | biostudies-literature
UnknownAssociation of H3K9me3 with breast cancer prognosis by estrogen receptor status.
Not available
S-EPMC9609245 | biostudies-literature
UnknownNovel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs.
Not available
S-EPMC6122384 | biostudies-literature
UnknownExtracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
Not available
S-EPMC10978711 | biostudies-literature
ProteomicsProteomic Characterization of Epithelial Ovarian Cancer Delineates Molecular Signatures and Therapeutic Targets in Distinct Histological Subtypes
Clear cell carcinoma (CCC), endometrioid carcinoma (EC), and serous carcinoma (SC) are the major histological subtypes of epithelial ovarian cancer (EOC), whose differences in carcinogenesis are still unclear. Here, we undertake comprehensive proteomic profiling of 80 CCC, 79 EC, 80 SC, and 30 contr...
ORGANISM(S): Homo sapiens (Human) 
2023-10-30 | PXD033741 | Pride
Epithelial ovarian cancer proteomics histological subtype tumor biomarkers drug target 
UnknownTricin selectively combats KRAS-mutant non-small cell lung cancer by inhibiting the PDGF-BB-induced SRC/MAPK/AP-1/PD-L1 signaling pathway and potentiating the antitumor effect of an anti-PD-1 antibody.
Not available
S-EPMC12209307 | biostudies-literature
Sort   by:  
 Page size